Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02739256 · ClinicalTrials.gov registry record · NA

Early Versus Late Voiding Trials After Prolapse Repair

A NA study, sponsored by University of Pittsburgh.

Terminated
Registry status
NA
Development phase
57
Enrollment target

NCT02739256 is a NA study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 57 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02739256, a NA study, was terminated before completion, sponsored by University of Pittsburgh.

TERMINATED
Registry status
NA
Development phase
57 participants
Enrollment target

Study Summary

The primary aim of this study is to determine if normal bladder function (the ability to empty the bladder during spontaneous urination) after surgical repair of pelvic organ prolapse returns faster in patients who have a retrograde voiding trial the day of surgery versus patients who have a retrograde voiding trial on postoperative day one. Half of participants will have a voiding trial 4 hours after surgery, while the other half will have the voiding trial postoperative day one.

Interventions

  • PROCEDURE Retrograde voiding trial

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2016-02
Est. Completion 2017-03-01
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT02739256

The ClinicalTrials.gov registry entry for NCT02739256 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Retrograde voiding trial is the first listed.

NCT02739256 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02739256 about?

NCT02739256 is a clinical study titled "Early Versus Late Voiding Trials After Prolapse Repair". The primary aim of this study is to determine if normal bladder function (the ability to empty the bladder during spontaneous urination) after surgical repair of pelvic organ prolapse returns faster in patients who have a retrograde voiding trial the day of surgery versus patients who have a retrogr...

What is the current status of trial NCT02739256?

This trial is currently terminated. It is a NA study. The enrollment target is 57 participants. The study started on 2016-02. Estimated completion is 2017-03-01.

What interventions are being tested in trial NCT02739256?

The interventions under investigation include: Retrograde voiding trial (PROCEDURE).

Who is sponsoring clinical trial NCT02739256?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.